Clinical trial
Retrospective Observational Study Of Subjects With Cytokine-Refractory Metastatic Renal Cancer Treated With Axitinib (AG-013736) To Estimate 5-Yr Survival
NCT01056263 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Observational Study Of Subjects With Cytokine-Refractory Metastatic Renal Cancer Treated With Axitinib (AG-013736) To Estimate 5-Yr Survival
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- December 31, 2010
- Enrollment
- 52 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.